KDM2B and breast cancer: It showed higher expression of FBXL10 in breast carcinomatous tissues compared with normal tissues (Fig. 1A), and analysis based on major subtypes of breast cancer indicated that FBXL10 exhibited the highest expression levels in triple-negative breast cancer tissues compared with other less malignant subclasses (Fig. 1B).